Status:
COMPLETED
Effect of Perioperative Sivelstat Administration for Liver Resection
Lead Sponsor:
Kochi University
Conditions:
Liver Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
It is reported that sivelstat improved and preserved the postoperative renal function in the orthopedic management. Moreover because sivelstat reduced the migration of neutrophil, it improved acute lu...
Detailed Description
Whether the incidence of postoperative morbidities, such as liver failure, renal failure, or congestive heart failure, was reduced by administration of perioperative sivelstat.
Eligibility Criteria
Inclusion
- liver disease which surgical management was indicated
Exclusion
- weight loss greater than 10 per cent during the previous 6 months, signs of distant metastasis, or of respiratory, renal or heart disease
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00738348
Start Date
April 1 2007
End Date
July 1 2008
Last Update
June 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kochi Medical School
Kohasu-Okocho, Nankoku, Japan, 783-8505